• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带来自人类免疫缺陷病毒1型精英控制者的gag蛋白酶的嵌合NL4-3病毒复制能力的HLA相关改变。

HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.

作者信息

Miura Toshiyuki, Brockman Mark A, Brumme Zabrina L, Brumme Chanson J, Pereyra Florencia, Trocha Alicja, Block Brian L, Schneidewind Arne, Allen Todd M, Heckerman David, Walker Bruce D

机构信息

Partners AIDS Research Center, Massachusetts General Hospital, 149 13th St., Room 5212, Charlestown, MA 02129, USA.

出版信息

J Virol. 2009 Jan;83(1):140-9. doi: 10.1128/JVI.01471-08. Epub 2008 Oct 29.

DOI:10.1128/JVI.01471-08
PMID:18971283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2612337/
Abstract

Human immunodeficiency virus type 1 (HIV-1)-infected persons who maintain plasma viral loads of <50 copies RNA/ml without treatment have been termed elite controllers (EC). Factors contributing to durable control of HIV in EC are unknown, but an HLA-dependent mechanism is suggested by overrepresentation of "protective" class I alleles, such as B27, B51, and B57. Here we investigated the relative replication capacity of viruses (VRC) obtained from EC (n = 54) compared to those from chronic progressors (CP; n = 41) by constructing chimeric viruses using patient-derived gag-protease sequences amplified from plasma HIV RNA and inserted into an NL4-3 backbone. The chimeric viruses generated from EC displayed lower VRC than did viruses from CP (P < 0.0001). HLA-B57 was associated with lower VRC (P = 0.0002) than were other alleles in both EC and CP groups. Chimeric viruses from B57(+) EC (n = 18) demonstrated lower VRC than did viruses from B57(+) CP (n = 8, P = 0.0245). Differences in VRC between EC and CP were also observed for viruses obtained from individuals expressing no described "protective" alleles (P = 0.0065). Intriguingly, two common HLA alleles, A02 and B07, were associated with higher VRC (P = 0.0140 and 0.0097, respectively), and there was no difference in VRC between EC and CP sharing these common HLA alleles. These findings indicate that cytotoxic T-lymphocyte (CTL) selection pressure on gag-protease alters VRC, and HIV-specific CTLs inducing escape mutations with fitness costs in this region may be important for strict viremia control in EC of HIV.

摘要

未经治疗而血浆病毒载量维持在<50拷贝RNA/ml的1型人类免疫缺陷病毒(HIV-1)感染者被称为精英控制者(EC)。促成EC对HIV持久控制的因素尚不清楚,但“保护性”I类等位基因如B27、B51和B57的过度表达提示了一种HLA依赖性机制。在此,我们通过构建嵌合病毒来研究从EC(n = 54)获得的病毒(VRC)与慢性进展者(CP;n = 41)的病毒相比的相对复制能力,嵌合病毒使用从血浆HIV RNA扩增并插入NL4-3骨架的患者来源的gag-蛋白酶序列构建。与CP的病毒相比,EC产生的嵌合病毒显示出更低的VRC(P < 0.0001)。在EC组和CP组中,HLA-B57与比其他等位基因更低的VRC相关(P = 0.0002)。来自B57(+) EC(n = 18)的嵌合病毒显示出比来自B57(+) CP(n = 8,P = 0.0245)的病毒更低的VRC。对于从未表达所述“保护性”等位基因的个体获得的病毒,也观察到了EC和CP之间VRC的差异(P = 0.0065)。有趣的是,两个常见的HLA等位基因A02和B07与更高的VRC相关(分别为P = 0.0140和0.0097),并且共享这些常见HLA等位基因的EC和CP之间的VRC没有差异。这些发现表明,细胞毒性T淋巴细胞(CTL)对gag-蛋白酶的选择压力会改变VRC,并且在该区域诱导具有适应性代价的逃逸突变的HIV特异性CTL可能对HIV精英控制者的严格病毒血症控制很重要。

相似文献

1
HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.携带来自人类免疫缺陷病毒1型精英控制者的gag蛋白酶的嵌合NL4-3病毒复制能力的HLA相关改变。
J Virol. 2009 Jan;83(1):140-9. doi: 10.1128/JVI.01471-08. Epub 2008 Oct 29.
2
Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.早期 gag 中的保护性 HLA 等位基因选择有助于降低 HIV-1 复制能力,而这种能力在慢性感染中可能在很大程度上得到补偿。
J Virol. 2010 Nov;84(22):11937-49. doi: 10.1128/JVI.01086-10. Epub 2010 Sep 1.
3
Impaired replication capacity of acute/early viruses in persons who become HIV controllers.急性/早期病毒复制能力受损的人成为 HIV 控制器。
J Virol. 2010 Aug;84(15):7581-91. doi: 10.1128/JVI.00286-10. Epub 2010 May 26.
4
Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.在未经治疗的日本个体中,Gag蛋白酶介导的HIV-1复制能力对临床参数缺乏显著影响。
Retrovirology. 2015 Nov 19;12:98. doi: 10.1186/s12977-015-0223-z.
5
Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.东非和西非 HIV-1 分离株中 Gag-蛋白酶复制能力的亚型特异性差异。
Retrovirology. 2021 May 5;18(1):11. doi: 10.1186/s12977-021-00554-4.
6
Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.HIV-1 型 C 亚型慢性感染中 gag-protease 介导的复制能力:与 HLA 类型和临床参数的关联。
J Virol. 2010 Oct;84(20):10820-31. doi: 10.1128/JVI.01084-10. Epub 2010 Aug 11.
7
Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.在 HLA-B*27:05/B*57:01 阳性传播受者中,超级感染后 HIV 疾病快速进展。
Retrovirology. 2018 Jan 16;15(1):7. doi: 10.1186/s12977-018-0390-9.
8
Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.HLA-B*52:01 驱动的逃逸突变对病毒复制能力的影响。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.02025-19.
9
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.HLA-B57/B*5801 人类免疫缺陷病毒1型精英控制者会选择与病毒复制能力降低和强烈细胞毒性T淋巴细胞[校正后]识别相关的罕见gag变体。
J Virol. 2009 Mar;83(6):2743-55. doi: 10.1128/JVI.02265-08. Epub 2008 Dec 30.
10
HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.HLA - B*57/58:01细胞毒性T淋巴细胞逃逸变体的HIV - 1复制适应性通过gag中补偿性突变的积累得以恢复。
PLoS One. 2013 Dec 5;8(12):e81235. doi: 10.1371/journal.pone.0081235. eCollection 2013.

引用本文的文献

1
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.尽管在 HIV 宫内传播后男性儿童未坚持抗逆转录病毒治疗,但仍持续出现病毒血症。
Nat Med. 2024 Oct;30(10):2796-2804. doi: 10.1038/s41591-024-03105-4. Epub 2024 Jun 6.
2
Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.东非和西非 HIV-1 分离株中 Gag-蛋白酶复制能力的亚型特异性差异。
Retrovirology. 2021 May 5;18(1):11. doi: 10.1186/s12977-021-00554-4.
3
Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.HIV-1 Pol 中的脆弱靶点用于基于减毒的疫苗设计。
Virology. 2021 Feb;554:1-8. doi: 10.1016/j.virol.2020.12.003. Epub 2020 Dec 10.
4
Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.朝着 T 细胞介导的控制或消除 HIV 储存库的方向前进:癌症免疫学的经验教训。
Front Immunol. 2019 Sep 10;10:2109. doi: 10.3389/fimmu.2019.02109. eCollection 2019.
5
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies.V1 区 gp120 中的罕见半胱氨酸对产生广谱中和抗体的精英抑制剂的影响。
Front Immunol. 2019 May 15;10:1021. doi: 10.3389/fimmu.2019.01021. eCollection 2019.
6
Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.细胞毒性 T 淋巴细胞特异性针对保守嵌合疫苗免疫原中 Pol 表位可有效抑制 HIV-1 复制。
J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.02142-18. Print 2019 Apr 1.
7
Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients.针对携带来自泰国北部患者循环株 gag/PR 的嵌合 NL4-3 病毒,一种锚蛋白重复蛋白对病毒组装的广谱抗病毒活性。
Viruses. 2018 Nov 13;10(11):625. doi: 10.3390/v10110625.
8
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.基因和机制解析 HIV 对宿主细胞免疫的适应性的亚型特异性
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01502-18. Print 2019 Jan 1.
9
Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.在 HLA-B*27:05/B*57:01 阳性传播受者中,超级感染后 HIV 疾病快速进展。
Retrovirology. 2018 Jan 16;15(1):7. doi: 10.1186/s12977-018-0390-9.
10
Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.在墨西哥独特且高度基因混合的宿主群体中,HIV上较弱的HLA印记。
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01128-17. Print 2018 Jan 15.

本文引用的文献

1
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.回复性突变在人类免疫缺陷病毒设定点的HLA关联中的核心作用。
J Virol. 2008 Sep;82(17):8548-59. doi: 10.1128/JVI.00580-08. Epub 2008 Jul 2.
2
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.精英控制者中1型人类免疫缺陷病毒的基因特征:不存在明显的基因缺陷或常见氨基酸变化。
J Virol. 2008 Sep;82(17):8422-30. doi: 10.1128/JVI.00535-08. Epub 2008 Jun 18.
3
Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.1型人类免疫缺陷病毒从一名发展为艾滋病的患者传播至一名精英抑制者。
J Virol. 2008 Aug;82(15):7395-410. doi: 10.1128/JVI.00800-08. Epub 2008 May 21.
4
Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.HIV-1衣壳蛋白免疫逃逸突变的传播与相关接受者体内病毒载量降低有关。
J Exp Med. 2008 May 12;205(5):1009-17. doi: 10.1084/jem.20072457. Epub 2008 Apr 21.
5
Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.结构和功能限制了人类免疫缺陷病毒1型衣壳中免疫显性的HLA - B27限制性表位中细胞毒性T淋巴细胞逃逸的选择。
J Virol. 2008 Jun;82(11):5594-605. doi: 10.1128/JVI.02356-07. Epub 2008 Apr 2.
6
Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.HIV-1细胞毒性T淋巴细胞逃逸变体的传播为HLA不匹配的受体提供了生存优势。
PLoS Pathog. 2008 Mar 21;4(3):e1000033. doi: 10.1371/journal.ppat.1000033.
7
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.未经治疗却能控制HIV感染的人群中的基因和免疫异质性。
J Infect Dis. 2008 Feb 15;197(4):563-71. doi: 10.1086/526786.
8
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.人类免疫缺陷病毒控制者:在无抗逆转录病毒治疗情况下持久控制病毒的机制
Immunity. 2007 Sep;27(3):406-16. doi: 10.1016/j.immuni.2007.08.010.
9
HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.与艾滋病进展缓慢相关的 HLA 等位基因确实更倾向于呈现 HIV-1 p24。
PLoS One. 2007 Sep 19;2(9):e920. doi: 10.1371/journal.pone.0000920.
10
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.在Gag中逃避主要的HLA - B27限制性细胞毒性T淋巴细胞反应与1型人类免疫缺陷病毒复制的显著减少有关。
J Virol. 2007 Nov;81(22):12382-93. doi: 10.1128/JVI.01543-07. Epub 2007 Sep 5.